Italy's Golden Goose Rules Out IPO This Year, Sees Limited Impact From Tariffs
Italian luxury sneaker maker Golden Goose still sees a market listing as an excellent opportunity but rules out an initial public offering this year and is leaving the door open to M&A options, its CEO told Reuters on Wednesday.
'An IPO remains a very good opportunity,' chief executive officer Silvio Campara told Reuters in a phone interview, adding that at the moment market conditions do not make that possible.
The company, which private equity firm Permira bought in 2020, tried to list on the Milan bourse last year, but pulled the offering because of market volatility.
The company, which produces its €500 ($565) sneakers in Italy, sees a limited impact from US tariffs.
'If you follow the first sale rule, tariffs are applied to production cost and not to the transfer price, so in our case the 20 percent tariffs will translate to a 4 percent impact,' Campara said. He added that the US represented roughly 40–45 percent of total revenue.
Within US customs law, the first sale rule provides the possibility for companies to pay duties on the price paid at the original manufacturer, under certain conditions.
The US has imposed a baseline 10 percent tariff on almost all countries, including Italy. It has lined up additional 'reciprocal' tariffs if negotiations during a 90-day pause should fail.
Golden Goose reported a 12 percent rise in net revenues at constant exchange rates to €164.5 million in the first quarter, driven by a strong performance in the Europe, Middle East and Africa region, it said earlier on Wednesday.
The company added it had opened three new stores during the quarter, with direct-to-consumer net revenues reaching 76 percent of total net revenues.
Earlier this year Blue Pool, a Hong Kong-based investment firm backed by Alibaba co-founder Joe Tsai, bought a 12 percent stake in Golden Goose.
By Elisa Anzolin; Edited by Cristina Carlevaro and Mark Potter
Learn more:
Golden Goose Kickstarts €480 Million Bond Sale to Refinance Debt
The luxury sportswear company plans to sell €480 million ($544 million) of senior secured floating-rate notes maturing in six years.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
China robotaxis, Indian pharma among hedge fund top picks at Sohn Hong Kong
By Summer Zhen HONG KONG (Reuters) -Hedge funds revealed their top investment ideas, ranging from Chinese self-driving taxis, an Indian drug retailer, to a Korean nuclear plant builder, at the annual Sohn investment conference in Hong Kong. This year's picks are geographically more diverse compared to last year, suggesting that investors are actively seeking to spread their exposure to counter tariff uncertainties and market volatility. San Francisco-based Flight Deck Capital sees upside potential in Chinese search engine giant Baidu, betting on its fast-growing auto-driving business. Similar to Google's self-driving unit Waymo, Baidu's Apollo Go "is the only robo-taxi player in China that's not dependent on the capital markets to scale," Flight Deck founder and managing partner Jay Kahn said at the conference on Friday. He expects China's taxi and ride-share industry to grow to around $237 billion by 2034, with Apollo taking a 15% market share. But that segment, together with Baidu's cloud business, is currently given zero valuation by the market, he said. Notably, investor optimism on Chinese firms going overseas has not been derailed by the escalating U.S.-China trade war. Hong Kong's Apeiron Capital pitched Chinese ride-hailing company DiDi Global, citing its improving margin at home and its quick market share building in Latin America. Meanwhile Triata Capital is upbeat on Chinese discount e-commerce player PDD, the owner of Temu. "One statistic that a lot of people don't know is that their MAU right now is bigger than Amazon," Triata CIO Sean Ho said, referring to Temu's monthly active users. INDIA Two investors set their sights on India's healthcare space. Singapore's Arisaig Partners favors MedPlus Health Services, a leading pharmacy chain in India, as its private label products strengthen its low-price proposition, widening the gap with competitors. "Inflation is lower, government is focusing on the middle class and consumer spending is coming off a low base. I simply believe this is the time when the consumer space in general will do better," Vatsal Mody, partner and head of India research at Arisaig Partners said in an interview ahead of the conference. India-based hedge fund startup Panvira Management is bullish on Piramal Pharma, a contract development and manufacturing organisation (CDMO), expecting its growth to accelerate to high teens and to benefit from tax rate normalisation. SECURITY AND ACTIVISTS Other emerging hedge funds focused on opportunities in the security sector driven by geopolitical conflicts. Jon Jhun, who manages Management's new Korea-focused fund, chose Hyundai Engineering & Construction, which engages in nuclear plant engineering, procurement and construction (EPC). "Korea dominates the ex-Russia, ex-China nuclear supply chain," he said. Hong Kong's Frontline Global Management picked Spanish defence firm Indra Sistemas, believing the firm will win more European contracts. On the activist investor side, UK hedge fund Palliser Capital disclosed a 3% stake in Japan's Toyo Tire at the event, urging the tire maker to boost shareholder returns by setting a "best-in-class" performance target and releasing its excess capital of about $900 million to shareholders. Seth Fischer's Oasis Management is long Japanese entertainment complex chain Round One, betting it will gain a re-rating as it ventures into the restaurant industry aiming to bring Michelin-quality Japanese food to the U.S.
Yahoo
an hour ago
- Yahoo
Citi names Bank of America veteran Zhang as new China country head
By Selena Li HONG KONG (Reuters) - Citigroup said on Monday it had appointed Wenjie Zhang as its new country officer and banking head for China, after the exit of its former China head in November. Zhang was also named president and executive director of Citibank China, the company said in a statement. The appointment is subject to regulatory approvals. He will act as the lead Citi representative and as its single, coordinated face in the mainland China market, the company said, leading the team and fostering strong regulatory relationships and risk controls. He will fill the role after former Citi China head Luke Lu left in November for personal reasons. Zhang will join Citi in July and will be based in Shanghai, reporting to Marc Luet, Citi's Head of Japan, Asia North and Australia and Banking, the bank said. A seasoned banker with 30 years of experience in corporate and institutional banking, Zhang was most recently the president of China and Shanghai branch manager for Bank of America China, according to Citi's statement. Prior to that, he was co-head of global banking and executive vice president at HSBC China, after stints at JPMorgan, Citi and Credit Agricole CIB. Citi is cutting up to 200 information technology (IT) contractor roles in China, two people familiar told Reuters last month, as the bank looks to hire its own staff globally for such operations to improve risk management and data governance. Citi, which already has a banking business in China, is in the process of setting up a securities unit in the country.
Bloomberg
an hour ago
- Bloomberg
New World's Distress Worsens After Shock Delay on Bond Interest
Hong Kong developer New World Development Co. is sliding deeper into distress after jolting investors by delaying interest payments on some bonds, marking the latest flashpoint in a years-long crisis in China's property market. New World, which is grappling with HK$210.9 billion ($26.9 billion) of liabilities, said in a filing late Friday that it's planning the deferment for coupons on four perpetual notes. In total, that means it's postponing $77.2 million of debt obligations, according to Bloomberg calculations.
